Case Letter

Woronoff Ring Associated With Adalimumab Therapy for Psoriasis

Kelly K. Park, MD; James W. Swan, MD; David Eilers, MD; Rebecca Tung, MD; John Koo, MD

In 1926, Woronoff first described a hypopigmented ring surrounding psoriatic plaques during UV treatment. Since then, the Woronoff ring has been noted with the use of psoralen plus UVA therapy, corticosteroids, the Goeckerman treatment, coal tar, anthralin, fumaric acid esters, and methotrexate, as well as over the natural course of untreated psoriasis. However, there is limited research investigating this phenomenon and only 1-sentence descriptions are typical in dermatologic textbooks. We report a case of Woronoff ring in association with adalimumab. Its presentation with the use of any biologic agent is unique.


 

Recommended Reading

NIH at Forefront of New Clinical Trials Push, Director Says
Psoriasis Collection
Blog: Top 10 Stories of 2011
Psoriasis Collection
Drug Therapies and Adjunctive Uses of Alphahydroxy and Polyhydroxy Acids
Psoriasis Collection
Epidemiology of Skin Diseases in People of Color
Psoriasis Collection
Over-the-Counter Topical Skin Products—A Common Component of Skin Disease Management
Psoriasis Collection
Common Dermatologic Disorders in Skin of Color: A Comparative Practice Survey
Psoriasis Collection
Cutaneous Manifestations of Diabetes Mellitus: A Case Series
Psoriasis Collection
Lasers and Light Devices for Psoriasis, Part 2: PDL, Nd:YAG Laser, CO2 Laser, and PDT
Psoriasis Collection
Product News: 10 2013
Psoriasis Collection